Focus on Facial Aesthetics Clinical Studies and Experience With
Bimatoprost and Botulinum Toxin Type A
This CME supplement to Skin & Allergy News® is supported by Allergan and is based on presentations made at Skin Disease Education Foundation's 33rd Annual Hawaii Dermatology SeminarTM.
• Topical Prostaglandin Treatment for Hypotrichosis: Overview of the Clinical Data
• Botulinim Toxin Type A Injectables: A Critical View of Similarities and Differences
Faculty/Faculty Disclosures
Dee Anna Glaser, MD
Professor and Vice Chairman
Department of Dermatology
Saint Louis University
St Louis, MO Dr Glaser is a consultant for Allergan.
Mark G. Rubin, MD
Associate Professor of Dermatology
University of California, San Diego
San Diego, CA Dr Rubin is a consultant for Medicis.
